|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Oct―16 |
Differential specificity of SARS-CoV-2 main protease variants on peptide versus protein-based substrates |
Fernanda R. Rocho, Scott J. Snipas, Anwar Shamim, Wioletta Rut, Marcin Drag, Carlos A. Montanari, Guy S. Salvesen |
2 |
[GO] |
2023―Sep―02 |
Identification of a novel inhibitor of SARS-CoV-2 main protease: an in silico, biochemical, and cell-based approach |
Aditya Trivedi, Vandana Kardam, Krishna Kishore Inampudi, Sudhanshu Vrati, Dharmender Gupta, Aekagra Singh, et al. (+3) Sarala Rani Kayampeta, Mohan Babu Appaiahgari, Deepak Sehgal |
3 |
[GO] |
2023―Apr―26 |
Gene silencing of endothelial von Willebrand factor reduces the susceptibility of human endothelial cells to
SARS-CoV
-2 infection |
Giulia Furini, Alessandro De Carli, Rossella Fonnesu, Pietro Giorgio Spezia, Francesca Scebba, Mauro Pistello, et al. (+2) Michele Lai, Vincenzo Lionetti |
4 |
[GO] |
2023―Apr―04 |
Structure and epitope of a neutralizing monoclonal antibody that targets the stem helix of β coronaviruses |
Ashlesha Deshpande, Nobert Schormann, Mike S. Piepenbrink, Luis Martinez Sobrido, James J. Kobie, Mark R. Walter |
5 |
[GO] |
2022―Oct―21 |
A Guide to COVID-19 Antiviral Therapeutics: A Summary and Perspective of the Antiviral Weapons Against SARS-CoV-2 Infection |
Drugan K. Brady, Aashi R. Gurijala, Liyu Huang, Ali A. Hussain, Audrey L. Lingan, Olivia G. Pembridge, et al. (+4) Brina A. Ratangee, Tristan T. Sealy, Kyle T. Vallone, Thomas P. Clements |
6 |
[GO] |
2022―Aug―26 |
Core fucose-specific
Pholiota squarrosa
lectin (
PhoSL
) as a potent broad-spectrum inhibitor of
SARS-CoV
-2 infection |
Kazuhiko Yamasaki, Naruhiko Adachi, Mya Myat Ngwe Tun, Akihito Ikeda, Toshio Moriya, Masato Kawasaki, et al. (+6) Tomoko Yamasaki, Tomomi Kubota, Izuru Nagashima, Hiroki Shimizu, Hiroaki Tateno, Kouichi Morita |
7 |
[GO] |
2022―Aug―02 |
Effects of natural
RNA
modifications on the activity of
SARS-CoV
-2
RNA
-dependent
RNA
polymerase |
Ivan Petushkov, Daria Esyunina, Andrey Kulbachinskiy |
8 |
[GO] |
2022―May―01 |
Emerging clinically tested detection methods for COVID-19 |
Milagros Castellanos, Álvaro Somoza |
9 |
[GO] |
2022―Feb―02 |
SARS-CoV-2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion |
Federica Quaglia, Edoardo Salladini, Marco Carraro, Giovanni Minervini, Silvio C.E. Tosatto, Philippe Le Mercier |
10 |
[GO] |
2021―Oct―20 |
Crystal structures of the SARS-CoV-2 nucleocapsid protein C-terminal domain and development of nucleocapsid-targeting nanobodies |
Zhenghu Jia, Chen Liu, Yuewen Chen, Heng Jiang, Zijing Wang, Jialu Yao, et al. (+4) Jie Yang, Jiaxing Zhu, Boqing Zhang, Zhiguang Yuchi |
11 |
[GO] |
2021―Oct―15 |
Cellular senescence as a source of SARS-CoV-2 quasispecies |
Ioannis Karakasiliotis, Nefeli Lagopati, Konstantinos Evangelou, Vassilis G. Gorgoulis |
12 |
[GO] |
2021―Sep―07 |
Protons to Patients: targeting endosomal Na
+
/H
+
exchangers against COVID-19 and other viral diseases |
Hari Prasad |
13 |
[GO] |
2021―Sep―07 |
Spotlight on COVID-19: eighteen months on |
Serena Zacchigna, Alessandro Marcello, Lawrence Banks |
14 |
[GO] |
2021―Jul―19 |
COVID-19 vaccines: what do we know so far? |
Paraminder Dhillon, Daniel Altmann, Victoria Male |
15 |
[GO] |
2021―Jul―06 |
Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2 |
Hongchun Lin, Xinxin Ma, Fang Xiao, Hua Su, Yaling Shi, Yuntao Liu, et al. (+4) Lan Song, Zhongde Zhang, Chun Zhang, Hui Peng |
16 |
[GO] |
2021―Jul―03 |
The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes |
ZhenWei Marcus Tong, Emma Grant, Stephanie Gras, Melanie Wu, Corey Smith, Helen L. Barrett, et al. (+2) Linda A. Gallo, Kirsty R. Short |
17 |
[GO] |
2021―Jun―29 |
Targeting Neuropilins as a viable SARS-CoV-2 treatment |
Sarvenaz Sarabipour, Feilim Mac Gabhann |
18 |
[GO] |
2021―May―17 |
Neurological consequences of neurovascular unit and brain vasculature damages: potential risks for pregnancy infections and COVID-19-babies |
Marco Rasile, Eliana Lauranzano, Filippo Mirabella, Michela Matteoli |
19 |
[GO] |
2021―May―10 |
Infection-induced inflammation from specific inborn errors of immunity to COVID-19 |
Cheng-Lung Ku, I-Ting Chen, Ming-Zong Lai |
20 |
[GO] |
2021―Apr―17 |
Host PDZ-containing proteins targeted by SARS-Cov-2 |
Célia Caillet-Saguy, Fabien Durbesson, Veronica V. Rezelj, Gergö Gogl, Quang Dinh Tran, Jean-Claude Twizere, et al. (+3) Marco Vignuzzi, Renaud Vincentelli, Nicolas Wolff |
21 |
[GO] |
2021―Mar―23 |
Non-optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts |
Gon Carmi, Alessandro Gorohovski, Sumit Mukherjee, Milana Frenkel-Morgenstern |
22 |
[GO] |
2021―Mar―12 |
New targets for drug design: Importance of nsp14/nsp10 complex formation for the 3’-5’ exoribonucleolytic activity on SARS-CoV-2 |
Margarida Saramago, Cátia Bárria, Vanessa G. Costa, Caio S. Souza, Sandra C. Viegas, Susana Domingues, et al. (+4) Diana Lousa, Cláudio M Soares, Cecília M Arraiano, Rute G. Matos |
23 |
[GO] |
2021―Feb―23 |
The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID-19 infection |
Eugene Merzon, Ilan Green, Shlomo Vinker, Avivit Golan-Cohen, Alessandro Gorohovski, Eva Avramovich, et al. (+2) Milana Frenkel-Morgenstern, Eli Magen |
24 |
[GO] |
2020―Dec―02 |
The Structural Basis of Accelerated Host Cell Entry by SARS-CoV-2
† |
Murat Seyran, Kazuo Takayama, Vladimir N. Uversky, Kenneth Lundstrom, Giorgio Palé, Samendra P. Sherchan, et al. (+18) Diksha Attrish, Nima Rezaei, Alaa A.A. Aljabali, Shinjini Ghosh, Damiano Pizzol, Gaurav Chauhan, Parise Adadi, Tarek Mohamed Abd El-Aziz, Antonio G Soares, Ramesh Kandimalla, Murtaza Tambuwala, Sk. Sarif Hassan, Gajendra Kumar Azad, Pabitra Pal Choudhury, Wagner Baetas-da-Cruz, Ángel Serrano-Aroca, Adam M. Brufsky, Bruce D. Uhal |
25 |
[GO] |
2020―Oct―30 |
The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection |
Darren Z.L. Mok, Candice Yuen Yue Chan, Eng Eong Ooi, Chan Kuan Rong |
26 |
[GO] |
2020―Oct―24 |
Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients |
Hao-Long Zeng, Chen Di, Jingjun Yan, Qing Yang, Qiang-Qiang Han, Shu-Sheng Li, Liming Cheng |
27 |
[GO] |
2020―Sep―27 |
Announcing the winners of our COVID-19 Creative Communication Competition |
Paraminder Dhillon |
28 |
[GO] |
2020―Sep―27 |
Spotlight on COVID-19: from biology to therapy and prevention |
Serena Zacchigna, Alessandro Marcello, Lawrence Banks |
29 |
[GO] |
2020―Sep―27 |
Vitamin D to prevent COVID-19: recommendations for the design of clinical trials |
Carlos A. Camargo, Adrian R. Martineau |
30 |
[GO] |
2020―Aug―13 |
Nicotine and the nicotinic cholinergic system in COVID-19 |
Yousef Tizabi, Bruk Getachew, Robert L. Copeland, Michael Aschner |
31 |
[GO] |
2020―Aug―01 |
Tumor markers as an entry for SARS-CoV-2 infection? |
Pu Xia, Anna Dubrovska |
32 |
[GO] |
2020―Jul―23 |
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study |
Eugene Merzon, Dmitry Tworowski, Alessandro Gorohovski, Shlomo Vinker, Avivit Golan Cohen, Ilan Green, Milana Frenkel Morgenstern |
33 |
[GO] |
2020―Jul―21 |
COVID-19, Cilia, and Smell |
Wei Li, Ming Li, Guangshuo Ou |
34 |
[GO] |
2020―Jul―12 |
Sympathetic activation: a potential link between comorbidities and COVID-19 |
Andrea Porzionato, Aron Emmi, Silvia Barbon, Rafael Boscolo-Berto, Carla Stecco, Elena Stocco, et al. (+2) Veronica Macchi, Raffaele De Caro |
35 |
[GO] |
2020―Jun―05 |
COVID-19 breakthroughs: separating fact from fiction |
Paraminder. Dhillon, Manuel. Breuer, Natasha. Hirst |
36 |
[GO] |
2020―May―23 |
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2 |
Cassandra L. Atzrodt, Insha Maknojia, Robert D.P. McCarthy, Tiara M. Oldfield, Jonathan Po, Kenny T.L. Ta, et al. (+2) Hannah E. Stepp, Thomas P. Clements |
37 |
[GO] |
2020―May―19 |
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing |
Oleg O. Glebov |
38 |
[GO] |
2020―May―17 |
Ligand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank |
Alexander Wlodawer, Zbigniew Dauter, Ivan Shabalin, Miroslaw Gilski, Dariusz Brzezinski, Marcin Kowiel, et al. (+3) Wladek Minor, Bernhard Rupp, Mariusz Jaskolski |
39 |
[GO] |
2020―Mar―19 |
Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? |
J.L. Olds, N. Kabbani |